
US biotech firm Alynlam has elected Pfizer’s former executive VP and general counsel Amy Schulman to its board of directors. …

A leading big pharma figurehead who was to be instrumental in Pfizer’s future plans has stepped down unexpectedly. Amy Schulman …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

